So far, our analyses revealed a specific sensitivity of mesenchymal neuroblastoma cell lines and fresh tissue tumoroids to MEK inhibitors, and a significant correlation of the mesenchymal-type with senescence phenotype-associated pathways. This evidence concerns the gene MAP2K7 and neuroblastoma.